Literature DB >> 15202556

Structure-related cytotoxicity and anti-hepatofibric effect of asiatic acid derivatives in rat hepatic stellate cell-line, HSC-T6.

Mi-Sook Dong1, Seung-Hyun Jung, Hyun-jung Kim, Jeong-Ran Kim, Long-Xuan Zhao, Eung-Seok Lee, Eun-Joo Lee, Jung Bum Yi, Namkyu Lee, Yong-Baik Cho, Wie Jong Kwak, Young In Park.   

Abstract

The structural relationship of 16 asiatic acid (AA) derivatives, including AA and asiaticoside (AS) to cytotoxicity and anti-hepatofibrotic activity in HSC-T6 cells, were investigated. Cytotoxicities of AA derivatives varied from 5.5 microM to over 2000 microM of IC50 depending on AA functional group modifications. Substituting the hydroxyl group at the C(2) to N[triple bond]C and substituting bulky groups for dihydroxyl groups at (3), (23) of the A-ring increased the cytotoxicity, but keto group at C(11) and benzoyl ester at C(2) were greatly reduced it. Modification of the carboxylic acid group at C28 also reduced the cytotoxicity. The collagen synthesis determined by hydroxyproline content in the cells was inhibited from a maximum of 48% (Zlx-i-85 and 87) to 15% (AS) by AA derivatives. The anti-hepatofibrotic effect of these compounds might be due to the reduced expression of prolyl 4-hydroxylase alpha and beta subunits and TIMP2. However, the inhibition of collagen by asiaticoside derivatives did not show any structural-activity relationship.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15202556     DOI: 10.1007/bf02980124

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  11 in total

Review 1.  Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise.

Authors:  Mohamed Fizur Nagoor Meeran; Sameer N Goyal; Kapil Suchal; Charu Sharma; Chandragouda R Patil; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

2.  Preparation and in vitro and in vivo Study of Asiaticoside-Loaded Nanoemulsions and Nanoemulsions-Based Gels for Transdermal Delivery.

Authors:  Huimin Li; Qian Peng; Yisha Guo; Xiaohui Wang; Li Zhang
Journal:  Int J Nanomedicine       Date:  2020-05-04

3.  Antinociceptive activities and the mechanisms of anti-inflammation of asiatic Acid in mice.

Authors:  Shyh-Shyun Huang; Chuan-Sung Chiu; Hsien-Jung Chen; Wen-Chi Hou; Ming-Jyh Sheu; Ying-Chih Lin; Pei-Hsin Shie; Guan-Jhong Huang
Journal:  Evid Based Complement Alternat Med       Date:  2011-04-20       Impact factor: 2.629

4.  Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.

Authors:  Li-xia Tang; Rui-hua He; Guang Yang; Jia-ju Tan; Li Zhou; Xiao-ming Meng; Xiao Ru Huang; Hui Yao Lan
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

5.  Effect of asiaticoside on endothelial cells in hypoxia‑induced pulmonary hypertension.

Authors:  Xiaobing Wang; Xueli Cai; Wu Wang; Yi Jin; Mayun Chen; Xiaoying Huang; Xiaochun Zhu; Liangxing Wang
Journal:  Mol Med Rep       Date:  2017-12-12       Impact factor: 2.952

6.  In Silico Analyses and Cytotoxicity Study of Asiaticoside and Asiatic Acid from Malaysian Plant as Potential mTOR Inhibitors.

Authors:  Ninie Nadia Zulkipli; Rahimah Zakaria; Idris Long; Siti Fadilah Abdullah; Erma Fatiha Muhammad; Habibah A Wahab; Teguh Haryo Sasongko
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

7.  Combination treatment with asiaticoside and rapamycin: A new hope for in-stent restenosis.

Authors:  Tian Guo; Ming Fang; Dadong Zhang; Xinming Li
Journal:  Exp Ther Med       Date:  2013-06-13       Impact factor: 2.447

8.  Asiatic acid inhibits left ventricular remodeling and improves cardiac function in a rat model of myocardial infarction.

Authors:  Lianying Huo; Wenbing Shi; Ling Chong; Jinlong Wang; Kai Zhang; Yufeng Li
Journal:  Exp Ther Med       Date:  2015-11-17       Impact factor: 2.447

9.  Asiaticoside might attenuate bleomycin-induced pulmonary fibrosis by activating cAMP and Rap1 signalling pathway assisted by A2AR.

Authors:  Jing Luo; Ting Zhang; Chengwei Zhu; Junwei Sun; Wenjing Zhu; Wenxiu Ai; Xiaoying Huang; Xiaobing Wang
Journal:  J Cell Mol Med       Date:  2020-06-16       Impact factor: 5.310

Review 10.  Medicinal Plants and Phytochemicals for the Treatment of Pulmonary Hypertension.

Authors:  Seyed Vahid Jasemi; Hosna Khazaei; Ina Yosifova Aneva; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Front Pharmacol       Date:  2020-03-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.